%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
2013-09-17T11:40:41+02:00
2013-09-17T11:40:41+02:00
2013-09-17T11:40:41+02:00
Adobe Acrobat 10.0
application/pdf
EACS 2013
uuid:0ac83630-454d-4e5a-8b74-9096fbbbfd65
uuid:f0a78aec-2af6-41c8-97c8-3e2aa965766e
Acrobat Web Capture 10.0
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>
endobj
10 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
11 0 obj
<>stream
/CS0 cs 1 scn
57 176.712 480.75 651.135 re
f
62.068 759.44 475.682 63.34 re
f
q
62.068 759.44 475.682 63.34 re
W n
q
/GS0 gs
475.6827906 0 0 -63.3399189 62.0671935 822.7796119 cm
/Im0 Do
Q
Q
62.068 752.472 475.682 6.968 re
f
62.068 755.639 475.682 0.634 re
f
0.604 scn
q 1 0 0 1 62.0676 756.2727 cm
0 0 m
0.633 -0.634 l
475.049 -0.634 l
475.682 0 l
h
f
Q
0.933 scn
q 1 0 0 1 62.0676 755.6391 cm
0 0 m
0.633 0 l
475.049 0 l
475.682 0 l
h
f
Q
0.604 scn
q 1 0 0 1 62.0676 755.6391 cm
0 0 m
0.633 0 l
0 0.634 l
h
f
Q
0.933 scn
q 1 0 0 1 537.1164 755.6391 cm
0 0 m
0.634 0 l
0.634 0.634 l
h
f
Q
1 scn
62.068 722.069 475.682 30.403 re
f
62.068 685.966 475.682 36.104 re
f
62.068 650.495 475.682 35.471 re
f
62.068 457.308 475.682 193.187 re
f
62.068 396.502 475.682 60.806 re
f
62.068 399.669 475.682 0.633 re
f
0.604 scn
q 1 0 0 1 62.0676 400.302 cm
0 0 m
0.633 -0.633 l
475.049 -0.633 l
475.682 0 l
h
f
Q
0.933 scn
q 1 0 0 1 62.0676 399.6693 cm
0 0 m
0.633 0 l
475.049 0 l
475.682 0 l
h
f
Q
0.604 scn
q 1 0 0 1 62.0676 399.6693 cm
0 0 m
0.633 0 l
0 0.633 l
h
f
Q
0.933 scn
q 1 0 0 1 537.1164 399.6693 cm
0 0 m
0.634 0 l
0.634 0.633 l
h
f
Q
BT
0 scn
/TT0 1 Tf
0.03 Tw 8.2342 0 0 8.2342 62.0672 734.7371 Tm
[(Poster)-33( Exhibition)-50( Presentation)]TJ
/TT1 1 Tf
-0.028 Tw 10.1344 0 0 10.1344 62.0672 712.5682 Tm
[(PE1/3)-26( -)-42( The)-34( Ability)-6( of)-56( the Highly)-6( Sensitive)-46( Enzyme)-33( Immunoassay)-18( for)-42( HIV)-20(-)-42(1)-6( P24)-33( Antigen)-28( Detection)]TJ
0 -1.187 TD
[(to)-56( Significantly)-54( Reduce)-13( Seroconversion)-4( Window)-42( Period)-13( at)-48( HIV)-20( Infection)]TJ
/TT0 1 Tf
0 Tw 34 0 Td
( )Tj
/TT2 1 Tf
/Span<>> BDC
-34 -1.187 Td
( )Tj
EMC
/TT0 1 Tf
0.03 Tw 8.2342 0 0 8.2342 62.0672 675.831 Tm
[(I.)-59( Sharipova)]TJ
ET
/CS0 CS 0 SCN
0.633 w
q 1 0 0 1 62.0672 675.1976 cm
0 0 m
44.971 0 l
S
Q
BT
/TT0 1 Tf
0 Tw 6.9674 0 0 6.9674 107.0385 678.998 Tm
(1)Tj
0.03 Tw 8.2342 0 0 8.2342 111.4723 675.831 Tm
[(,)-30( V.)-55( Puzyrev)]TJ
0 Tw 6.9674 0 0 6.9674 157.0771 678.998 Tm
(1)Tj
0.03 Tw 8.2342 0 0 8.2342 161.5109 675.831 Tm
[(,)-30( A.)-55( Obriadina)]TJ
0 Tw 6.9674 0 0 6.9674 213.4496 678.998 Tm
(1,2)Tj
0.03 Tw 8.2342 0 0 8.2342 223.584 675.831 Tm
[(,)-30( A.)-55( Burkov)]TJ
0 Tw 6.9674 0 0 6.9674 265.3883 678.998 Tm
(1)Tj
0.03 Tw 8.2342 0 0 8.2342 269.8221 675.831 Tm
[(,)-30( T.)-34( Ulanova)]TJ
0 Tw 6.9674 0 0 6.9674 315.4269 678.998 Tm
(1,2)Tj
/Span<>> BDC
8.2342 0 0 8.2342 325.5612 675.831 Tm
( )Tj
EMC
/TT3 1 Tf
6.9674 0 0 6.9674 62.0672 666.33 Tm
(1)Tj
0.03 Tw 8.2342 0 0 8.2342 66.501 663.163 Tm
[(RPC)-43( Diagnostic)-24( Systems,)-42( Nizhniy)-30( Novgorod,)-2( Russian)-3( Federation,)-19( )]TJ
0 Tw 6.9674 0 0 6.9674 311.6265 666.33 Tm
(2)Tj
0.03 Tw 8.2342 0 0 8.2342 316.0603 663.163 Tm
[(DSI)-25( S.R.L,)-67( Saronno,)-19( Italy)]TJ
/TT1 1 Tf
0 Tw -30.846 -2.462 Td
[(Background:)-64( )]TJ
/TT0 1 Tf
0.03 Tw 6.538 0 Td
[(Despite)-71( the)-72( use)-3( state)-63( of)-12( the)-71( art)-64( serological)-67( assays)-42( for)-64( screening)-50( of)-12( blood)-16( donations,)-1( there)-29( are)-16( cases)-3( of)-12( infection)]TJ
-6.538 -1.231 Td
[(through)-70( transfusion)-32( of)-12( blood)-16( and)-24( its components.)-44( Samples)-33( obtained)-10( from seronegative)-44( donors)-20( during)-67( \223window\224)-77( period)-67( pose)-63( the)]TJ
0 -1.231 TD
[(most)-64( significant)-15( hazard.)-50( The)-46( only)-12( way)-68( to)-12( reduce)-20( the)-71( seronegative)-44( window)-51( of)-12( HIV)-25( infection)-45( is)-47( increase)-67( the)-71( assay)-3( sensitivity)-51( at)]TJ
T*
[(detecting)-19( early)-64( marker)-43( of)-12( p24)-24( antigen.)-57( The)-46( aim)-4( of)-12( this)-59( study)-71( is)-47( to)-12( show)-51( the)-71( possibility)-51( of)-12( a)-59( highly)-3( sensitive)-33( kit for)-64( detection)-19( of)]TJ
0 Tw T*
[(HIV)-25(-)-52(1)-59( )]TJ
/C2_0 1 Tf
3 0 Td
<026A>Tj
/TT0 1 Tf
0.03 Tw 0.615 0 Td
[(24)-42( antigen)-28( to)-12( reduce)-20( the)-71( serological)-67( window)-51( of)-12( HIV)-25( infection)-45( and)-24( thereby)-50( to)-12( reduce)-20( the)-72( risk)-60( of)-12( post)-33( transfusion)-32( infection.)]TJ
/TT1 1 Tf
0 Tw -3.615 -1.231 Td
[(Materials:)-24( )]TJ
/TT0 1 Tf
0.03 Tw 5 0 Td
[(The)-46( assay)-3( DS)-72(-)-52(EIA)-3(-)-52(HIV)-25(-)-52(AG)-16(-)-52(Screen)-63( \()]TJ
/C2_0 1 Tf
0 Tw 16.692 0 Td
<024B023F>Tj
/TT0 1 Tf
6.9674 0 0 6.9674 252.7204 590.3221 Tm
(0483)Tj
0.03 Tw 8.2342 0 0 8.2342 268.5553 592.2223 Tm
[(\))-52( intended)-10( only)-12( for)-64( HIV)-25(-)-52(1)-59( p24)-24( antigen)-28( detection)-19( with)-68( sensitivity)-51( 0.025)]TJ
-25.077 -1.692 Td
[(IU/ml)-52( \(\223HIV)-52(-)-52(1)-59( p24)-24( ANTIGEN)-17( 1)]TJ
0 Tw 6.9674 0 0 6.9674 175.4456 581.4545 Tm
(st)Tj
0.03 Tw 8.2342 0 0 8.2342 181.1462 578.2875 Tm
[( international)-14( reference)-7( reagent\224)-45( NIBSC,)-51( UK\). 22)-42( seroconversion)-66( panels)-54( produced)-62( by)]TJ
-14.462 -1.231 Td
[(ZeptoMetrix)-29( and)-24( Sera)-42( Care)-64( \(USA\))-47( have)-63( been)-7( tested.)-75( )]TJ
/TT1 1 Tf
0 Tw T*
[(Results:)-55( )]TJ
/TT0 1 Tf
0.03 Tw 4.308 0 Td
[(The)-46( kit with)-68( sensitivity)-51( 0.025)-36( IU/ml)-52( detected)-10( the)-71( p24)-24( antigen)-28( at)-12( the)-72( same)-16( time)-34( as)-21( viral)-13( RNA)-43( in)-68( 19)-42( of)-12( 22)-42( seroconversion)]TJ
-4.308 -1.231 Td
[(panels.)-7( In)-12( ZeptoMetrix)-29( panel)-15( HIV)-25( 9077)-7( it)-38( was)-68( even)-63( 4)-59( days)-42( earlier)-68( than)-54( viral)-13( RNA.)-72( On)-51( the)-71( two)-59( panels)-54( ZeptoMetrix)-29( HIV6243)-32( and)]TJ
T*
[(BBI)-3( PRB966)-45( p24)-24( antigen)-28( was)-68( detected)-10( on)-42( 2)-59( and)-24( 7)-59( days)-42( later)-55( in)-68( comparison)-63( with)-68( NAT respectively.)-58( Compared)-24( to)-12( NAT,)]TJ
T*
[(detection)-19( of)-12( HIV)-25( infection)-45( by)-21( the)-72( DS)-73(-)-52(EIA)-3(-)-52(HIV)-25(-)-52(AG)-17(-)-52(Screen)-63( is)-47( on)-42( average)-2( only)-12( delayed)-36( by)-21( about)-36( 0.25)-54( days)-42( but)-71( enables)-36( to)-12( reduce)]TJ
T*
[(seroconversion)-66( window)-51( period)-67( by)-21( 2.25)-54( days)-42( in)-68( comparison)-63( with)-68( kits)-38( with)-68( the)-72( sensitivity)-51( 0.25)-54( IU/ml,)-4( by)-21( 2.75)-54( days)-42( in)-68( comparison)]TJ
T*
[(with)-68( kits)-38( with)-68( the)-72( sensitivity)-51( 0.5)-71( IU/ml)-52( and)-24( by)-21( 5.78)-54( days)-42( in)-68( comparison)-63( with)-68( kits)-38( with)-68( the)-72( sensitivity)-51( 1.25)-54( IU/ml.)]TJ
/TT1 1 Tf
0 Tw 0 -1.231 TD
[(Conclusion:)-68( )]TJ
/TT0 1 Tf
0.03 Tw 6.154 0 Td
[(The)-46( increasing)-58( sensitivity)-51( of)-12( EIA)-3( at)-12( HIV)-25(-)-52(1)-59( p24)-24( antigen)-28( detection)-19( allow)-30( significantly)-63( reduce)-20( serological)-67( window)]TJ
-6.154 -1.231 Td
[(period)-67( during)-67( HIV)-25( infection)-45( and)-24( thereby)-50( ensure)-20( earlier)-68( detection)-19( of)-12( HIV)-25( infection)-45( and)-24( increase)-67( safety)-24( level)-21( of)-12( donated)-1( blood.)]TJ
0 Tw /Span<>> BDC
6.334 0 0 6.334 62.0672 459.2085 Tm
( )Tj
EMC
/TT1 1 Tf
0.03 Tw 8.2342 0 0 8.2342 62.0672 449.7075 Tm
[(Abstract)-21( Details)]TJ
/TT0 1 Tf
0.154 -1.385 Td
[(Abstract)-24( Number:)]TJ
/Span<>> BDC
7.846 0 Td
( )Tj
EMC
0 Tw 3.769 0 Td
(PE1/3)Tj
0.03 Tw -11.615 -1.462 Td
[(Session)-58( Title:)]TJ
/Span<>> BDC
6.154 0 Td
( )Tj
EMC
5.462 0 Td
[(Poster)-33( Session)-58( 1&2)]TJ
-11.615 -1.462 Td
[(Abstract)-24( Category:)]TJ
/Span<>> BDC
8.385 0 Td
( )Tj
EMC
3.231 0 Td
[(1.)-12( Virology)-3( \(incl.)-43( Molecular)-51( Virology,)-33( Diversity,)-43( excl.)-21( Resistance\))]TJ
0 Tw /Span<>> BDC
6.334 0 0 6.334 62.0672 405.3695 Tm
( )Tj
EMC
ET
endstream
endobj
12 0 obj
<>
endobj
13 0 obj
(w̫mjmK>)
endobj
22 0 obj
<>stream
Adobe d
'$''''$25552;;;;;;;;;;
%%#(((((#,0000,7;;;7;;;;;;;;;;
%%#(((((#,0000,7;;;7;;;;;;;;;; d "
!1"AQ2STaqB#36Rt
$%&'()*45789:CDEFGHIJUVWXYZbcdefghijrsuvwxyz
!1AQq"2RTa
#$%&'()*3456789:BCDEFGHIJSUVWXYZbcdefghijrstuvwxyz ? B?#n# }B%eK8[9 eR*FSςbrvbLKv8OB2-)uiB8[JIQ`SN )$AY
.B,JɷuIJ c̬eG(o,UTHybrE^"v]JQHuIJ,fiW`p8mvuqjS9F+0v^JTN%kդhP+sl)u,)ćV Cd5-&E$l 31!qPB.(Nc_u
`qX B 32̂qzfVrVuty"RA$`+yC8JlRHoe3pYz:iKL)B~9dgmŶ>*tٱu2*AMYNbZ+2aRZrr]BT:P#"*0e5|Q2z%
Nt9#" JMV2}/P vaP + \(Z I$ 3# MKbB~$
Ⰴa(+
:}-[_ N ^c2l>wPFWc{bkxK:10t.
,TVawd6N F$Z8fVe\ܥ@m E&*Gu3M4[(/1Z-u:L(a)K>3!R^CMR U˂(=s6 )iI6 Mdm\)
QI2'ld1RZZjr]kYR[R; W*II)T `=w,ZTXf̄aWJM6z@8̝TN8o; j(H 2D͌EYDM<F.--y"#0KbR$mme5UWZfbD#ViOKwQW*\SOMl-Ҡx*U14h\#bOiLL6MY@
m{j2l5AiEqcPLe<1td122M٧i.rJت'䜗3h}4fb\QUTd
S"s͂bD"љ)F5Ĕۍ҂Сt$)$p6ԥ@LvmјB5 EsBBBBH BBBBBBBBB +B!B!V!B#INiQ锅ʙmCe˓xV
5 0!rL-ԣ$a
6 &7Ӵii\zZ`'z]z=r r)F]e).qMtŷDijT[Pt/lF29KQ2 %uϞ14Ғ-ʲPZPA((3xZ G"|;zNهeP(qҹqlk1rb+4 :XqN"8
ލ[2HQ͜v\m*Cs -,S%Y¥lmKB%&R,
PA6c9WeqlQjd8)'vnH~=Idݘ}`[XJe )]Y9l`NAj8{v9ʚB┅*!%yF%s
(LIZX(b{rtfK
raE[){Z/ѥf9}\JRëhHr( YtڕJkR9&r ]djPY'uP̥4ŷ*wC,TpEe\wIjm".լm@vFlDyqj֡ˡVÒrtyI)MF
k)ՄAQ9^8eIq j*6Jv19&,i$Իq([8ҢQs}aN2B`R(60Ԭ@qs4IdL#hÃ2AG%EZ*%+p(TJD3qU<-kM;DS!-h Ik &WgZ&JJJK8~VJ)OJIJH.RFBD0&yK@)BEdb,Ulc)L#杔x
,a`Eֻ`NBVH˯νĔ
m cv$%%l'T{i6ófͰQm: ReV@H-*7]uI$\'J"3͊ friXJC4TqĹhrvmL
bR֔bۄ#a
Z)%!S$Ue MӾvh)mUթ4UcHe
"|O!%Kr@:jK}SJ).iBv$(ҏSJlÏq-HXJn!m-`SIr (P(V$N#5-hi/;.HQJJ\ XshTT.4aj
lnR"b%5)O4eZZНT8$6)Mr6RH"-zUА VH.13
eJSέ}йt
)!7xF>@ZT8J1Ĝ